Latest news
Aribio completes global phase 3 Alzheimer trial, readies topline results - CHOSUNBIZ - ChosunbizChosunbiz · Tue, 28 Jul 2026 07:00:00 GMTAriBio wraps up global phase 3 trial of AR1001, sets stage for topline results - koreabiomed.comkoreabiomed.com · Tue, 28 Jul 2026 01:01:35 GMTAribio and ForeverNK join to develop next-gen Alzheimer’s drugs in South Korea - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 27 Jul 2026 07:00:00 GMT